-
Endocarditis
Endocarditis with combination treatment
Extraintestinal
Intravenous
Intravenous, Oral
Investigational agent
Liposomal, Inhaled
Mammary gland
Mastitis
Meningitis
Meningitis, Endocarditis
Metritis
Non-endocarditis
Non-meningitis
Non-meningitis, Non-endocarditis
Non-pneumonia
Oral
Oral, Infections originating from the urinary tract
Oral, Other indications
Oral, Uncomplicated urinary tract infection
Parenteral
Pneumonia
Prophylaxis
Respiratory
Respiratory, genital
Respiratory, soft tissue
Screen
Skin
Skin, respiratory
Skin, soft tissue
Skin, soft tissue, respiratory
Skin, soft tissue, respiratory, uncomplicated urinary tract infection
Skin, soft tissue, respiratory, uncomplicated urinary tract infection, genital
Skin, soft tissue, uncomplicated urinary tract infection
Skin, uncomplicated urinary tract infection
Uncomplicated urinary tract infection
Uncomplicated urinary tract infection, Investigational agent
Wounds, abscesses
Wounds, abscesses, uncomplicated urinary tract infection

These are conditions used in EUCAST or CLSI 2025 Breakpoints, sourced from AMR R package using this command:
clinical_breakpoints %>% filter(guideline=="CLSI 2025" | guideline=="EUCAST 2025") %>% group_by(site) %>% count() 